Cite
APA Citation
Pena, M. J., de Zeeuw, D., Andress, D., Brennan, J. J., Correa‐Rotter, R., Coll, B., Kohan, D. E., Makino, H., Perkovic, V., Remuzzi, G., Tobe, S. W., Toto, R., Parving, H., Sharma, S., Corringham, T., Sharma, K., & Heerspink, H. J. L. (2017). the effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy. Diabetes, obesity & metabolism, 19(5), 749–753. http://access.bl.uk/ark:/81055/vdc_100045730955.0x00000a